Consensus Takeda Pharmaceutical Company Limited NYSE

Stocks

TAK

US8740602052

Pharmaceuticals

Market Closed - NYSE 01:30:03 31/10/2026 am IST			5-day change	1st Jan Change
20.91 ^USD	+4.50%		+3.31%	+34.12%

30/10	Asian Equities Traded in the US as American Depositary Receipts Fall Sharply in Friday Trading	MT
30/10	Takeda Pharmaceutical Bets on Three New Drugs for Up to $11 Billion in Peak Sales	MT

92d2fb8fe25c30d.riCD02tu76NWjvvQhjI0KZkMCOI9a_TMYmS70301RcA.6Wyz5zIKrNQ16Nbpy2RFc8Z7f4tyI8OoAyzw4EhFKbr2SdarGhqpkzO8vg~998ab457dfe38d0f900bee9ec5eeb656

Analysts' recommendations: Takeda Pharmaceutical Company Limited

30/10	Macquarie Adjusts Takeda Pharmaceutical's Price Target to 7,600 Yen	MT
31/08	Protagonist Therapeutics' Own Pipeline Seen as Main Long-Term Growth Driver, Wedbush Says	MT
28/07	SBI Securities Starts Takeda Pharmaceutical at Neutral with 5,400 Yen Price Target	MT
24/07	China Merchants Starts Takeda Pharmaceutical at Buy with 6,600 Yen Price Target	MT
30/03	Alumis' Drug 'Very Positive' for Treatment of Psoriasis, Systemic Lupus Erythematosus, Oppenheimer Says	MT
30/01	Jefferies Adjusts Takeda Pharmaceutical's Price Target to 5,700 Yen From 5,100 Yen, Keeps at Buy	MT
11/11	Neurocrine Biosciences' Depressive Disorder Drug Fails to Meet Primary Goal in Phase 2 Study	MT
26/25/26	Alkermes' Stock Dip on Narcolepsy Data Seen as Buying Opportunity, RBC Says	MT
21/25/21	Veeva Systems Q2 Results Likely In-Line to Better, Maintain H2 Outlook, Truist Says	MT
09/25/09	Jefferies Adjusts Takeda Pharmaceutical's Price Target to 5,100 Yen From 5,500 Yen, Keeps at Buy	MT
06/25/06	Jefferies Adjusts Takeda Pharmaceutical Company's Price Target to 5,500 Yen From 5,000 Yen, Keeps at Buy	MT
12/24/12	Jefferies Adjusts Takeda Pharmaceutical's Price Target to 5,000 Yen From 4,800 Yen, Keeps at Buy	MT
31/24/31	Jefferies Adjusts Takeda Pharmaceutical's Price Target to 4,800 Yen From 5,600 Yen, Keeps at Buy	MT
13/24/13	Jefferies Adjusts Takeda Pharmaceutical's Price Target to 5,600 Yen From 5,200 Yen, Keeps at Buy	MT
03/23/03	Jefferies Adjusts Takeda Pharmaceutical’s Price Target to 5,200 Yen From 5,300 Yen, Keeps at Buy	MT
22/23/22	Jefferies Adjusts Takeda Pharmaceutical’s Price Target to 5,300 Yen From 5,100 Yen, Keeps at Buy	MT
31/23/31	Jefferies Adjusts Takeda Pharmaceutical’s Price Target to 5,100 Yen From 5,000 Yen, Keeps at Buy	MT
16/23/16	TD Cowen Adjusts Price Target on Takeda Pharmaceutical to $20 From $30, Maintains Outperform Rating	MT
04/23/04	TD Cowen Adjusts Price Target on Takeda Pharmaceutical to $30 From $24, Keeps Outperform Rating	MT
16/23/16	BofA Securities Upgrades Takeda Pharmaceutical to Buy From Neutral, Price Target $20	MT
06/23/06	Jefferies Adjusts Takeda Pharmaceutical’s Price Target to 5,000 Yen From 4,600 Yen, Keeps at Buy	MT
01/22/01	Jefferies Downgrades Takeda Pharmaceutical to Hold From Buy	MT
19/22/19	Cowen Upgrades Takeda Pharmaceutical to Outperform From Market Perform	MT
07/21/07	Takeda Pharmaceutical : Morgan Stanley Downgrades Takeda Pharmaceutical to Equal-weight From Overweight	MT
09/17/09	Bayer : Germany's Merck hires JP Morgan to sell consumer health	RE

More recommendations

Other Pharmaceuticals

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	ELI LILLY AND COMPANY					-1.45%
	JOHNSON & JOHNSON					+2.27%
	ABBVIE INC.					-3.97%
	ROCHE HOLDING AG					-2.72%
	MERCK & CO., INC.					+7%
	NOVARTIS AG					-5.37%
	ASTRAZENECA PLC					+12.5%
	AMGEN INC.					-14.74%
	GILEAD SCIENCES, INC.					-3.15%
	Average					-1.07%
	Weighted average by Cap.					-0.77%